Industrial biotechnology company, Verdezyne, has completed a new round of financing. The new investors in this round are BP Alternative Energy Ventures and DSM Venturing. The two investors have joined the existing ones, OVP Venture Partners and Monitor Ventures. The additional financing will allow Verdezyne to continue building its yeast metabolic engineering capabilities to produce a pipeline of renewable transportation fuels and platform chemicals.

Click here for the release from Business Wire.